DeepMind AlphaFold 3 Predicts Complex Biology
Google DeepMind releases AlphaFold 3, a groundbreaking AI model that predicts structures of proteins, DNA, RNA, and liga…
17 articles about 'Drug Discovery'
Google DeepMind releases AlphaFold 3, a groundbreaking AI model that predicts structures of proteins, DNA, RNA, and liga…
Google DeepMind launches AlphaFold 3, a breakthrough AI model predicting molecular structures with unprecedented accurac…
Google DeepMind releases AlphaFold 3, achieving unprecedented accuracy in predicting complex biomolecular structures.
Quantum computing startup Liangkun raises significant angel funding to provide high-precision data for AI-driven scienti…
Pharma giant Merck deploys advanced machine learning to accelerate genomic research and drug discovery.
Swiss pharma giant Roche partners with NVIDIA to accelerate AI-driven drug discovery and personalized medicine using adv…
Google DeepMind unveils AlphaFold 4, achieving 97% accuracy in predicting protein-drug interactions and reshaping pharma…
SoftBank-backed Japanese startup Sakana AI unveils a new foundation model purpose-built for biological research and drug…
Google DeepMind's AlphaFold 3 dramatically accelerates molecular structure prediction, reshaping how pharmaceutical comp…
Google DeepMind unveils AlphaFold 4, achieving atomic-level accuracy in modeling how drugs bind to proteins.
Fujitsu and RIKEN unveil a hybrid quantum-classical computing platform designed to accelerate pharmaceutical drug discov…
Google DeepMind launches AlphaFold 4, achieving unprecedented accuracy in protein structure prediction and expanding to …